Neochromosome, Inc. Email Format
Biotechnology ResearchNew York, United States11-50 Employees
Neochromosome, Inc. operates in biotechnology research with a focus on enabling genome-scale biological engineering. The company provides synthetic DNA and cell engineering services that support researchers investigating novel therapeutics, more sustainable products, and groundbreaking scientific inquiry. Its offerings span automated DNA synthesis and the design, construction, and delivery of chromosomes, including the capacity to design, assemble, and evaluate eukaryotic cells built entirely from synthetic components. Headquartered in New York City, New York, Neochromosome is a small-to-mid-sized organization serving researchers and partners worldwide. In December 2023, it announced a collaboration with the University of Edinburgh that aims to leverage artificial intelligence to accelerate the creation of designer enzymes.